Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacoepidemiology and rheumatic disorders.

K Arnold Chan1, Sonia Hernandez-Diaz

  • 1Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA. kachan@hsph.harvard.edu

Rheumatic Diseases Clinics of North America
|October 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patterns and risk factors of hyperkalemia recurrence among heart failure patients.

Frontiers in cardiovascular medicine·2026
Same author

Systematic Evaluation of Data and Trial Fitness for Oncology Trial Emulation: Empirical Findings from the CARE Initiative.

Clinical pharmacology and therapeutics·2026
Same author

Incidence of human papillomavirus infections in women aged 27 years and older in the US: A federated data network study.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Re: Liu et al., "On the reported methodology in published TriNetX-based studies: an analysis of impossible index event designs".

European journal of epidemiology·2026
Same author

Editorial: Advancement of RWD/RWE utilization for enhancing drug development and benefit/risk assessment.

Frontiers in pharmacology·2026
Same author

The Impact of Immortal Time Bias on Survival Estimates of Patients with Heart Failure with Improved Ejection Fraction.

CJC open·2026

Pharmacoepidemiology aids in evaluating rheumatic disorder drugs, focusing on safety and effectiveness. This review covers NSAIDs, pregnancy outcomes, alendronate safety, and methotrexate benefits for rheumatoid arthritis.

Area of Science:

  • Rheumatology
  • Pharmacoepidemiology
  • Drug Safety

Background:

  • Rheumatic disorders require long-term medication management.
  • Evaluating drug safety and efficacy in real-world settings is crucial.

Purpose of the Study:

  • To review the application of pharmacoepidemiology in assessing drugs for rheumatic conditions.
  • To highlight data sources and methodologies for pharmacoepidemiological studies.

Main Methods:

  • Review of existing literature on pharmacoepidemiology in rheumatology.
  • Discussion of data sources and methodological considerations.

Main Results:

  • Safety evaluation of nonsteroidal anti-inflammatory drugs (NSAIDs).
  • Assessment of adverse pregnancy outcomes associated with pharmaceutical agents.

Related Experiment Videos

  • Gastroduodenal safety of alendronate.
  • Long-term benefits of methotrexate for rheumatoid arthritis.
  • Drug utilization studies in rheumatic populations.

    • Conclusions:

    • Pharmacoepidemiology is essential for understanding the real-world impact of rheumatic drugs.
    • Methodological rigor is key to reliable pharmacoepidemiological findings in rheumatology.